Literature DB >> 8267604

Angiogenin enhances actin acceleration of plasminogen activation.

G F Hu1, J F Riordan.   

Abstract

Angiogenin interacts with actin to form a complex, which like actin itself, can accelerate plasmin generation by tissue plasminogen activator (tPA). In contrast to actin, the angiogenin-actin complex does not inhibit plasmin activity. In the presence of the angiogenin-actin complex, the overall proteolytic activity of a mixture of plasminogen and tPA is 11-fold higher than in its absence and 6-fold higher than in the presence of actin alone. These results suggest that binding and displacement of cell surface actin by angiogenin might be involved in cell migration and tumor invasion, processes that depend on the proteolytic degradation of basement membrane and the extracellular matrix. Therefore, the activity of the angiogenin-actin complex reported here may have physiological and pathological significance in the process of angiogenin-induced angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267604     DOI: 10.1006/bbrc.1993.2533

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.

Authors:  Nitika Paudel; Sathish Sadagopan; Sandhya Balasubramanian; Bala Chandran
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.

Authors:  Sujoy Dutta; Chirosree Bandyopadhyay; Virginie Bottero; Mohanan V Veettil; Lydia Wilson; Michael R Pins; Karen E Johnson; Case Warshall; Bala Chandran
Journal:  Mol Oncol       Date:  2014-01-04       Impact factor: 6.603

Review 3.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.

Authors:  Virginia Urquidi; Steve Goodison; Jeongsoon Kim; Myron Chang; Yunfeng Dai; Charles J Rosser
Journal:  Urology       Date:  2012-03-03       Impact factor: 2.649

5.  Angiogenin in sera as an independent prognostic factor in gastric cancer.

Authors:  Shouji Shimoyama; Michio Kaminishi
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

Review 6.  Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Authors:  Lili Chen; Guo-fu Hu
Journal:  Oral Oncol       Date:  2010-07-24       Impact factor: 5.337

7.  The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multiple.

Authors:  Constantina A Pappa; George Tsirakis; Anna Boula; Aikaterini Sfiridaki; Fotios E Psarakis; Michael G Alexandrakis; Efstathios N Stathopoulos
Journal:  Pathol Oncol Res       Date:  2013-02-28       Impact factor: 3.201

Review 8.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

9.  Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.

Authors:  G Hu; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.

Authors:  Virginie Bottero; Sathish Sadagopan; Karen E Johnson; Sujoy Dutta; Mohanan Valiya Veettil; Bala Chandran
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.